Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verseput, G. H.
Right arrow Articles by Koomans, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verseput, G. H.
Right arrow Articles by Koomans, H. A.

Journal of the American Society of Nephrology, Vol 8, 249-259, Copyright © 1997 by American Society of Nephrology


REGULAR ARTICLES

Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat

GH Verseput, AP Provoost, BB Braam, JJ Weening and HA Koomans
Department of Pediatric Surgery, Erasmus University Rotterdam, The Netherlands.

The spontaneously hypertensive fawn-hooded rat (FHH) develops accelerated albuminuria and focal glomerular sclerosis (FGS), leading to ESRD and shortening of lifespan. The FHH is characterized by moderate systemic hypertension, a relatively low afferent to efferent arteriolar resistance ratio, and glomerular hypertension. The FHH study presented here was designed to examine the efficacy of early-onset, late-onset, or early-temporary angiotensin I-converting enzyme inhibition (ACE-i) in ameliorating long-term hypertension and FGS, and improving survival, as well as to relate its protective efficacy to preexistent FGS and to reduction of glomerular pressure (PGC) Untreated rats developed hypertension and high PGC, and all (N = 22) except one died of ESRD within the 72-wk follow-up period. Early-onset (at 7 wk of age) ACE-i prevented development of systemic and glomerular hypertension, and it largely prevented proteinuria and FGS; all rats survived throughout the follow-up period. Rats treated with late-onset (22 wk) ACE-i were hypertensive and proteinuric at the start of ACE-i, and they showed beginning FGS. ACE-i corrected the hypertension, albuminuria, and PGC but could not fully prevent some hypertension, albuminuria, and FGS at the later stage. Early-temporary (7 to 22 wk) ACE-i adequately controlled blood pressure and development of FGS during therapy, but after withdrawal of ACE-i, systemic and glomerular hypertension developed as in untreated animals. This regimen postponed but did not control FGS development and early mortality. The results of this study indicate that: (1) early-onset ACE-i very effectively protects against development of renal damage in the FHH; (2) this protection is associated with normalization of the elevated glomerular capillary pressure; (3) ACE-i cannot completely prevent further development of previously established FGS, despite lowering glomerular capillary pressure; (4) early-temporary ACE-i has no long-term controlling effect on arterial and glomerular pressure, and it cannot control development of FGS.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
P. Ochodnicky, R. H. Henning, H. J. Buikema, D. de Zeeuw, A. P. Provoost, and R. P. E. van Dokkum
Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat
Am J Physiol Renal Physiol, March 1, 2010; 298(3): F625 - F633.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Abbate and G. Remuzzi
Can We Really Lessen Kidney Damage to the Point that the Loss of Renal Function of Progressive Nephropathy May Revert?
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1411 - 1414.
[Full Text] [PDF]


Home page
HypertensionHome page
E. Turkstra, B. Braam, and H. A. Koomans
Normal TGF Responsiveness During Chronic Treatment With Angiotensin-Converting Enzyme Inhibition : Role of AT1 Receptors
Hypertension, November 1, 2000; 36(5): 818 - 823.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. P. E. van Dokkum, H. J. Jacob, and A. P. Provoost
Blood pressure and the susceptibility to renal damage after unilateral nephrectomy and L-NAME-induced hypertension in rats
Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1337 - 1343.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. S. Reddi, V. R. Nimmagadda, A. Lefkowitz, H.-R. Kuo, and J. S. Bollineni
Effect of Antihypertensive Therapy on Renal Injury in Type 2 Diabetic Rats With Hypertension
Hypertension, August 1, 2000; 36(2): 233 - 238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Wang, D. O. Ajikobi, F. C. Salevsky, and W. A. Cupples
Impaired myogenic autoregulation in kidneys of Brown Norway rats
Am J Physiol Renal Physiol, June 1, 2000; 278(6): F962 - F969.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. P. E. Van Dokkum, M. Alonso-Galicia, A. P. Provoost, H. J. Jacob, and R. J. Roman
Impaired autoregulation of renal blood flow in the fawn-hooded rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R189 - R196.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. L. A. Blezer, K. Nicolay, P. R. D. Bar, R. Goldschmeding, G. H. Jansen, H. A. Koomans, J. A. Joles, and F. M. Faraci
Enalapril Prevents Imminent and Reduces Manifest Cerebral Edema in Stroke-Prone Hypertensive Rats • Editorial Comment
Stroke, August 1, 1998; 29(8): 1671 - 1678.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. P. Provoost, M. Shiozawa, R. P. E. Van Dokkum, and H. J. Jacob
Transfer of the Rf-1 region from FHH onto the ACI background increases susceptibility to renal impairment
Physiol Genomics, February 28, 2002; 8(2): 123 - 129.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP